Extrahepatic manifestations associated to hepatitis C virus;Manifestations extrahepatiques associees au virus de l'hepatite C

Medecine et Maladies Infectieuses

Volumn 30, Issue SUPPL. 1, 2000, Pages 34-42

  Cacoub, P ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Antinuclear antibodies; Antismooth muscle antibodies; Arthralgia: myalgia; Autoantibodies; Autoimmune thrombopenia; Cryoglobulin; Extrahepatic manifestations; Hepatitis C virus; Malignant lymphoproliferative diseases; Membranous proliferative glomerulonephritis; Pruritus; Sicca syndrome; Systemic vasculitis; Thyroxins

Indexed keywords

AUTOANTIBODY; CRYOGLOBULIN; THYROXINE;

CLINICAL FEATURE; CONFERENCE PAPER; CRYOGLOBULINEMIA; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LYMPHOPROLIFERATIVE DISEASE; MEDICAL LITERATURE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; PORPHYRIA CUTANEA TARDA; SJOEGREN SYNDROME; VASCULITIS;

EID: 0034163624     PISSN: 0399077X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (69)

1. Sharara AI, Hunt CM, Hamilton JD. Hepatitis C. Ann Intern Med 1996; 125: 658-68.
2. Gumber SC, Chopra SC. Hepatitis C: A multifaced disease. Review of extrahepatic manifestations. Ann Intern Med 1995; 123: 615-20.
3. Musset L, Diemert MC, Taibi F, Thi Huong Du L, Cacoub P, Léger JM, et al. Characterization of cryoglobulins by immunoblotting. Clin Chem 1992; 38: 798-802.
4. Gorevic PD, Kassab HJ, Levo Y, Kohn R, Meltzer M, Prose P, Franklin EC. Mixed cryoglobulinemia: Clinical aspects and long- term follow-up of 40 patients. Am J Med 1980; 69: 287-308.
5. Ferri C, Greco F, Longombardo G, Palla P, Moretti A, Marzo E, et al. Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia. Arthritis Rheum 1991; 34: 1606-10.
6. Pawlotsky JM, Roudot-Thoraval F, Simmonds P, Mellor J, Ben Yahia MB, André C, et al. Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med 1995; 122: 169-73.
7. Misiani R, Bellavita P, Fenili D, Borelli G, Marchesi D, Massazza M, et al. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med 1992; 117: 573-7.
8. Cacoub P, Musset L, Lunel-Fabiani F, Léger JM, Le Thi Huong Du, Wechsler B, et al. Hepatitis C virus and essential mixed cryoglobulinemia. Br J Rheumatol 1993; 32: 685-92.
9. Agnello V, Chung RT, Kaphan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992: 327: 1490-5.
10. Wong VS, Egner W, Elsey T, Brown D, Alexander GJ. Incidence, character and clinical relevance of mixed cryoglobulinaemia in patients with chronic hepatitis C virus infection. Clin Exp Immunol 1996; 104: 25-31.
11. Cacoub P, Lunel-Fabiani F, Musset L, Perrin M, Frangeul L, Leger JM, et al. Mixed cryoglobulinemia and hepatitis C virus. Am J Med 1994; 96: 124-32.
12. Apartis E, Léger JM, Musset L, Gugenheim M, Cacoub P, Lyon Caen O, et al. Peripheral neuropathy associated with essential mixed cryoglobulinemia: A role for hepatitis C virus infection? J Neurol Neurosurg Psychiatr 1996; 60: 661-6.
13. Lunel F, Musset L, Cacoub P, Frangeul L, Cresta P, Perrin M, et al. Cryoglobulinemia in chronic liver diseases: Role of hepatitis C virus and liver damage. Gastroenterology 1994; 106: 1291-1300.
14. Zignego AL, Ferri C, Giannini C, Monti M, La Civita L, Careccia G, et al. Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia. Ann Intern Med 1996; 124: 31-4.
15. Frangeul L, Musset L, Cresta P, Cacoub P, Huraux JM, Lunel F. Hepatitis C virus genotypes and subtypes in patients with hepatitis C, with and without cryoglobulinemia. J Hepatol 1996; 25: 427-32.
16. Misiani R, Bellavita P, Fenili D, Vicari O, Marchesi D, Sironi PL, et al. Interferon alpha-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994; 330: 751-57.
17. Casato M, Agnello V, Pucillo LP, Knight GB, Leoni M, Del Vecchio S, et al. Predictors of long-term response to high-dose interferon therapy in type II cryoglobulinemia associated with hepatitis C virus infection. Blood 1997; 90: 3865-73.
18. Durand JM, Cacoub P, Lunel-Fabiani F, Cretel E, Kaplanski G, Cosserat J, et al. Ribavirin in hepatitis C related cryoglobulinemia. J Rheumatol 1998; 25: 1115-17.
19. Cacoub P, Poynard T, Ghillani P, Charlotte F, Olivi M, Piette JC, Opolon P, MultivirC Group. Extrahepatic manifestations in patients with chronic hepatitis C. Arthritis Rheum 1999; 42: 2204- 12
20. Dammaco F, Sansonno D, Han JJ, Shyamala V, Cornacchiulo V, Iacobetti AR, et al. Natural interferon alfa versus its combination with 6-methyl-prednisolone on the therapy of type II mixed cryoglobulinemia: A long-term, randomized, controlled study. Blood 1994; 84: 3336-43.
21. Zuckerman E, Slobodin G, Tamir A, et al. Treatment of refractory, symptomatic HCV-related mixed cryoglobulinemia (MC) with ribavirin and interferon alfa [Abstract]. Hepatology 1998; 284: 375.
22. Johnson RJ, Gretch DR, Yamabe H, Hart J, Bacchi CE, Hartwell P, et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993; 328: 465-70.
23. Yamabe H, Johnson RJ, Gretch RD, Fukushi K, Osawa H, Miyata M, et al. Hepatitis C virus infection and membranoproliferative glomerulonephritis in Japan. J Am Soc Nephrol 1995; 6: 220-3.
24. D'Amico G. Renal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis. Nephrology Forum. Kidney Int 1998; 54: 650-71.
25. Lang P, Weil B. Low prevalence of hepatitis C virus antibodies among adult patients with primary glomerulonephritis in France. Nephron 1993; 63: 367.
26. Rostoker G, Deforges L, Ben Maadi A, Rémy P, Lang P, Duval JR, et al. Low prevalence of antibodies to hepatitis C virus among adult patients with idiopatic membranoproliferative type I glomerulonephritis in France (letter). Nephron 1995; 69: 97.
27. Gonzalo A, Fernandez M, Navarro J, Ortuño J. Searching for hepatitis C viurs antibodies in chronic primary glomerular diseases (letter). Nephron 1995; 69: 96.
28. Cribier B, Petiau P, Keller F, Schmitt C, Vetter D, Heid E, et al. Porphyria cutanea tarda and hepatitis C virus infection: A clinical and virological study. Arch Dermatol 1995; 131: 801-4.
29. Herrero C, Vicente A, Bruguera M, Ercilla MG, Barrera JM, Vidal J, et al. Is hepatitis C virus infection a trigger of porphyria cutanea tarda? Lancet 1993; 341: 788-9.
30. Strötzel U, Köstler E, Koszka C, Stöffler-Meilicke M, Schuppan D, Somasundaram R, et al. Low prevalence of hepatitis C virus infection in porphyria cutanea tarda in Germany. Hepatology 1995; 21: 1500-2.
31. Lacour JP, Bodokh I, Castanet J, Bekri S, Ortonne JP. Porphyria cutanea tarda and antibodies to hepatitis C virus. Br J Dermatol 1993; 128: 121-3.
32. Piperno A, Vergani A, Malosio I, Parma L, Fossati L, Ricci A, et al. Hepatic iron overload in patients with chronic viral hepatitis: Role of HFE gene mutations. Hepatology 1998; 28: 1105-9.
33. Pawlotsky JM, Ben Yahia M, Andre C, Voisin MC, Intrator L, Roudot-Thoraval F, et al. Immunological disorders in C virus chronic active hepatitis: A prospective case-control study. Hepatology 1994; 19: 841-8.
34. Clifford BD, Donahue D, Smith L, Cable E, Luttig B, Manns M, et al. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 1995; 21: 613-9.
35. Cacoub P, Renou C, Rosenthal E, Cohen P, Loury I, Loustaud- Ratti V, et al. Extrahepatic manifestations associated with hepatitis C virus infection: A prospective multicenter study of 321 patients. Medicine 2000: 79; 47-56.
36. Cacoub P, Musset L, Hausfater P, Ghillani P, Fabiani F, Charlotte F, et al. No evidence for abnormal immune activation in peripheral blood T cells in patients with hepatitis C virus infection (HCV) with or without cryoglobulinemia. Clin Exp Immunol 1998; 113: 48-54.
37. Cacoub P, Musset L, Amoura Z, Ghillani P, Chabre H, Lunel F, et al. Anti-cardiolipin, anti-β2 glycoprotein 1, and antinucleosome antibodies in hepatitis C virus infection with or without mixed cryoglobulinemia. J Rheumatol 1997; 24: 2139-44.
38. Haddad J, Deny P, Munz-Gotheil C, Ambrosini JC, Trinchet JC, Pateron D, et al. Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 1992; 339: 321-3.
39. Jorgensen C, Legouffe MC, Perney P, Coste J, Tissot B, Segarra C, et al. Sicca syndrome associated with hepatitis C virus infection. Arthritis Rheum 1996; 43: 1166-71.
40. King PD, Mc Murray RW, Becherer PR. Sjogren's syndrome without mixed cryoglobulinemia is not associated with hepatitis C virus infection. Am J Gastroenterol 1994; 89: 1047-50.
41. Ferri C, Caracciolo F, Zignego AL, La Civita L, Monti M. Longombardo G, et al. Hepatitis C virus infection in patients with non- Hodgkin's lymphoma. Br J Haematol 1994; 88: 392-4.
42. Mazzaro C, Zagonel V, Monfardini S, Tulissi P, Pussini E, Fanni M, et al. Hepatitis C virus and non-Hodgkin's lymphomas. Br J Haematol 1996; 94: 544-50.
43. Mc Coll MD, Singer IO, Tait RC, McNeil IRR, Cumming RLC, Hogg RB. The role of hepatitis C virus in the aetiology of non-Hodgkin's lymphoma - a regional association? Leuk Lymph 1997; 26: 127-30.
44. Hausfater P, Cacoub P, Bernard N, Loustaud-Ratti V, Le Lostec Z, Laurichesse F, et al. Hepatitis C virus infection and malignant lymphoproliferative disease: French national study. Arthritis Rheum 1998; 41: 307.
45. Zuckerman E, Zuckerman T, Levine AM, Douer D, Gutekunst K, Mizokami M, et al. Hepatitis C virus infection in patients with B- cell non-Hodgkin lymphoma. Ann Intern Med 1997; 127: 423-8.
46. Germanidis G, Haioun C, Pourquier J, Gaulard P, Pawlotsky JM, Dumeaux D, et al. Hepatitis C virus infection in patients with overt B-cell non-Hodgkin's lymphoma in a french center (letter). Blood 1999; 33: 1778-9.
47. Hausfater P, Sterkers Y, Thibault V, Crétel E, Nguyen L, Leblond V, et al. [Abstract]. Absence de surprévalence du virus de l'hépatite C au cours des lymphomes non hodgkiniens: Étude propsective controlée. Rev Med Interne 1999; 20: 87.
48. Cacoub P, Lunel-Fabiani F, Musset L, Opolon P, Piette JC. Hepatitis C virus and mixed cryoglobulinemia (letter). N Engl J Med 1993; 328: 1121-2.
49. Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, et al. Binding of hepatitis C virus to CD81. Science 1998; 282: 938-41.
50. Marcellin P, Deschamps V, Martinot-Peignoux M, Larzul D, Xu L, Boyer N, et al. Cryoglobulinemia with vasculitis associated with hepatitis C virus infection. Gastroenterology 1993; 104: 272-7.
51. Cacoub P, Lunel-Fabiani F, Le Thi Huong D. Polyarteritis nodosa and hepatitis C infection. Ann Intern Med 1992; 116: 605-6.
52. Dény P, Bonacorsi S, Guillevin L, Quint L. Association between hepatitis C virus and polyarteritis nodosa. Clin Exp Rheumatol 1992; 10: 319-24.
53. Carson CW, Conn DL, Czaja AJ, Wright TL, Brecher ME. Frequency and significance of antibodies to hepatitis C virus in polyarteritis nodosa. J Rheumatol 1993: 20: 304-9.
54. Cacoub P, Gatel A, Maisonobe T, Thibault V. Hausfater P, Servan J, et al. Polyarteritis nodosa type versus symptomatic mixed cryoglobulinemia in hepatitis C patients. Arthritis Rheum 1998; 41: 245.
55. Cacoub P, Sbai A, Hausfater P, Papo T, Gatel A, Piette JC. Atteinte neurologique centrale et infection par le virus de l'hépatite C. Gastroenterol Clin Biol 1998; 22: 631-33.
56. Pawlotsky JM, Bouvier M, Fromont P, Deforges L, Duval J, Dhumeaux D. et al. Hepatitis C virus infection and autoimmune thrombocytopenic purpura. J Hepatol 1995; 23: 635-9.
57. Nagamine T, Ohtuka T, Takehara K, Arai T, Takagi H, Mori M. Thrombocytopenia associated with hepatitis C viral infection. J HePatol 1996; 24: 135-40.
58. Bauduer F, Marty F, Larrouy M, Ducout L. Immunologic thrombocytopenic purpura as presenting symptom of hepatitis C infection. Am J Hematol 1998; 57: 338-40.
59. Jaccard A, Loustaud V, Turlure P, Rogez S, Bordessoule D. Ribavirin and immune thrombocytopenic purpura (letter). Lancet 1998; 351: 1660-1.
60. Dupin N, Chosidow O, Lunel F, Cacoub P, Musset L, Cresta P, et al. Essential mixed cryoglobulinemia. A comparative study of dermatologic manifestations in patients infected or non infected with hepatitis C virus. Arch Dermatol 1995; 131: 1124-7.
61. Seigel LB, Cohn L, Nashel D. Rheumatic manifestations of hepatitis C infection. Semin Arthritis Rheum 1993; 23: 149-54.
62. Ueno Y, Kinoshita R, Kishimoto I, Okamoto S. Polyarthritis associated with hepatitis C virus infection. Br J Rheumatol 1994; 33: 289-91.
63. Lovy MR, Sarkebaum G, Uberoi S. Hepatitis C infection presenting with rheumatic manifestations. A mimic of rheumatoid arthritis. J Rheumatol 1996; 23: 979-83.
64. Cribier B, Garnier C, Laustriat D, Heid E. Lichen planus and hepatitis C virus infection: An epidemiologic study. J Am Acad DermaTol 1994; 31: 1070-2.
65. Jubert C, Pawlotsky JM, Pouget F, André C, Deforges L, Bretagne S. et al. Lichen planus and hepatitis C virus-related chronic active hepatitis. Arch Dermatol 1994; 130: 73-6.
66. Sanchez-Perez J, De Castro M, Buezo GF, Fernandez-Herera J, Borque MJ, Garcia-Diez A. Lichen planus and hepatitis C virus: Prevalence and clinical presentation of patients with lichen planus and hepatitis C virus infection. Br J Dermatol 1996; 134: 715-9.
67. Marcellin P, Pouteau M, Benhamou JP. Hepatitis C virus infection, alpha interferon therapy and thyroid dysfunction. J Hepatol 1995; 22: 364-9.
68. Cacoub P, Sbai A, Frances C, Chapelon C. Hausfater P, Papo T. Piette JC. Sarcoïdose systémique après traitement par interferon alpha pour une hépatite C [Abstract]. Rev Med Interne 1999; 20: 120.
69. Lidove O, Cacoub P, Hausfater P, Sbai A, Léger JM, Frances C, Piette JC. Cryoglobulinémie et hépatite C: Aggravation de la multinévrite après interféron alpha (quatre cas). Gastroenterol Clin Biol 1999; 23: 403-6.